title: Successful use of single-lumen, urokinase immobilized femoral catheters as a temporary access for haemodialysis.
abstract: METHODS
  Placement of a femoral vein catheter as a temporary vascular access for haemodialysis was conducted and the indications, catheter patency rate, and incidence of catheter-related infections were examined. An urokinase immobilized femoral vein catheter (UIFC) is a soft polyurethane single-lumen catheter 2.7 mm in diameter and 22 cm in length which needs no heparin infusion (Japan Shawood Co., Ltd., Tokyo; Unitica Co., Ltd., Hyogo, Japan). A soft silicon rubber was attached to the tip of the catheter in order to avoid excessive bleeding during insertion. Aseptic adhesive wound dressing was employed at the exit-site which was cleansed with popidone-iodine and renewed at each dialysis session.
  
  
  RESULTS
  Eighty-one UIFCs were used for haemodialysis in 64 patients (acute renal failure: 11; vascular access trouble: 53; initiation of chronic dialysis: 17). The average age of the patients was 58 +/- 13 years, ranging from 26 to 80 years. The mean duration of catheter indwelling was 22.4 +/- 13.1 days. An adequate blood flow of 180-200 ml/min was obtained through UIFC and returned to another peripheral vein punctured at each dialysis session. Unexplained fever occurred in four cases while the UIFC was in place (4.9%) but culture of either blood or the catheter tip was negative for bacteria. The catheter was removed immediately and fever subsided in all cases. The overall catheter survival rate was 84% at 34 days calculated using the Kaplan-Meier method. Catheter insertion was easy to perform and no serious complications such as pulmonary embolism or septicaemia occurred.
  
  
  CONCLUSIONS
  Our modified type of UIFC is very useful as a temporary access for haemodialysis with a very low incidence of catheter-related infections and no need for heparinization. Excellent catheter patency was maintained with the plug system and careful dressing techniques without unnecessary bleeding during catheter care.
authors.affiliation: Kidney Center, Matsuyama Red Cross Hospital, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Takeda
authors.forename: A
authors.initials: A
authors.lastname: Harada
authors.forename: M
authors.initials: M
authors.lastname: Kubo
authors.forename: T
authors.initials: T
authors.lastname: Inenaga
authors.forename: K
authors.initials: K
authors.lastname: Tsuruya
authors.forename: K
authors.initials: K
authors.lastname: Mitsuiki
authors.forename: H
authors.initials: H
authors.lastname: Hirakata
authors.forename: M
authors.initials: M
authors.lastname: Fujishima
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002408:Catheters, Indwelling / Q000009:adverse effects; D004800:Enzymes, Immobilized / Q000494:pharmacology*; D005260:Female; D005268:Femoral Vein; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology*
chemical_list: D004800:Enzymes, Immobilized; D014568:Urokinase-Type Plasminogen Activator